| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Nektar Therapeutics (NKTR) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. NKTR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 75.9K | $4.99M | - | |
| Other | 21.6K | $1.42M | - | |
| Other | 15.4K | $1.01M | -5,538 | |
| Dir | 8.0K | $525.6K | - | |
| Dir | 8.0K | $525.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2023 | Zalevsky Jonathan63 | Chief R&D Officer | Sell | 9,703 | $0.78 | $7,568.34 | -3.3% | -33.6% | +54.9% | |
| Aug 16, 2023 | Wilson Mark Andrew58 | Chief Legal Officer | Sell | 7,221 | $0.78 | $5,632.38 | -2.8% | -33.6% | +54.9% | |
| Aug 16, 2023 | Robin Howard W58 | President &CEO | Sell | 19,998 | $0.78 | $15,598.44 | -2.1% | -33.6% | +54.9% | |
| Jun 14, 2023 | Whitfield Roy A | Director | Sell | 30,000 | $0.57 | $17,100.00 | -12.2% | +19.6% | +126.9% | |
| May 16, 2023 | Robin Howard W58 | President &CEO | Sell | 20,361 | $0.72 | $14,659.92 | -2.1% | +15.2% | +155.9% | |
| May 16, 2023 | Zalevsky Jonathan63 | Chief R&D Officer | Sell | 9,791 | $0.72 | $7,049.52 | -3.2% | +15.2% | +155.9% | |
| May 16, 2023 | Wilson Mark Andrew58 | Chief Legal Officer | Sell | 7,543 | $0.72 | $5,430.96 | -2.8% | +15.2% | +155.9% | |
| Feb 16, 2023 | Zalevsky Jonathan63 | Chief R&D Officer | Sell | 10,484 | $3.00 | $31,452.00 | -3.3% | -76.5% | -76.1% | |
| Feb 16, 2023 | Wilson Mark Andrew58 | Chief Legal Officer | Sell | 8,275 | $3.00 | $24,825.00 | -3.0% | -76.5% | -76.1% | |
| Feb 16, 2023 | Thomsen Jillian B.86 | Chief Financial Officer | Sell | 10,267 | $3.00 | $30,801.00 | -3.2% | -76.5% | -76.1% |